通过虚拟查和分子动力学模拟,发现潜在的GPRC5D抑制剂
Xi Chen1,2, Xinle Yang3, Roufen Chen4
1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China.
ChemistryOpen
|September 7, 2025
概括
研究人员确定了G蛋白结合受体家族C,组5,成员D (GPRC5D) 的潜在小分子抑制剂,GPRC5D是多发性髓瘤的关键标. 这项计算研究为发现针对GPRC5D的治疗方法提供了一种新方法.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- G蛋白结合受体家族C,第5组,成员D (GPRC5D) 是血液恶性瘤,特别是多发性骨髓瘤的有前途的免疫治疗点.
- 之前没有系统的虚拟查研究确定了GPRC5D的小分子抑制剂.
研究的目的:
- 开发和应用一种计算策略,用于识别针对GPRC5D的小分子抑制剂.
- 发现新型GPRC5D向治疗血液恶性瘤的新疗法.
主要方法:
- 一个多步骤的虚拟选工作流程,集成了PLANET,Vina-GPU,MM/GBSA和admetSAR 3.0.0.
- 用于验证的分子动力学 (MD) 模拟和绝对结合自由能量 (ABFE) 计算.
- 一个8617个组合图书馆的选.
主要成果:
- 从最初的库中优先考虑了四个候选化合物 (1,2,7和8).
- 化合物2表现出强大的结合亲和力 (MM/GBSA ΔG = -79.8 kcal/mol,ABFE = -9.0 kcal/mol) 和高度的药物相似性 (QED = 0.670).
- MD模拟证实了化合物2与关键残留物ASP238和ASP239.9的稳定相互作用.
结论:
- 该研究成功建立了一个系统的虚拟查工作流程,用于发现GPRC5D抑制剂.
- 这种方法有助于识别多发性骨髓瘤和其他血液恶性瘤的潜在GPRC5D向治疗方法.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.2K
08:21Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
7.3K
相关概念视频
G Protein-coupled Receptors
16.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.6K
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
